HLUBF:OTCMKTS
H Lundbeck A/S Class A
$6.85
0.00%
(0.00) 1D
Oct 8, 1:38:30 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HLUBF...
Mkt. cap
54.89B
Avg. vol.
108.00
Volume
1.00
52-wk high
$6.85
52-wk low
$4.82
Beta
0.85
Shares outstanding
199.15M
No. of employees
5K
Mkt. cap
54.89B
Avg. vol.
108.00
Volume
1.00
52-wk high
$6.85
52-wk low
$4.82
Beta
0.85
Shares outstanding
199.15M
No. of employees
5K
News stories
From web sources and news partners
FXEmpire
·
2 hours ago
S&P 500 Price Forecast: Strong Jobs Data Tests Rebound After AI Rout
Investing.com
·
9 hours ago
Poland’s Domanski blames presidential vetoes as S&P cuts outlook to negative
富途牛牛
·
6 hours ago
The S&P 500 Could Be Dangerously Exposed to AI. Here Are Some Simple Alternatives.
Traders Union
·
4 hours ago
Hedge fund performance lags S&P 500 at end of October, Peter Berezin notes
Profile
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine. Wikipedia
About H Lundbeck A/S Class A
CEOCharl Van Zyl
Employees5K
Founded1915
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitelundbeck.com